Takaya Nagasaki
Overview
Explore the profile of Takaya Nagasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubota Y, Ban T, Nagasaki T, Takahama T, Tanida S, Joh T
Endoscopy
. 2022 Aug;
54(S 02):E1047-E1048.
PMID: 36007903
No abstract available.
2.
Kimura M, Eguchi Y, Kuwabara Y, Mitsui A, Nagasaki T, Nakaya S, et al.
Langenbecks Arch Surg
. 2021 Feb;
406(4):1233-1237.
PMID: 33598848
Purpose: One of the complications in laparoscopic surgery is port-site hernia. It is a rare but potentially dangerous complication. Especially when using ports with a size 10 mm or more,...
3.
Hagui E, Kimura M, Katada T, Nagasaki T, Nakaya S, Eguchi Y, et al.
J Surg Case Rep
. 2021 Jan;
2020(12):rjaa552.
PMID: 33391661
The use of laparoscopic surgery has become widespread in recent years. One of its complications is port site hernia (PHS). It can be difficult to close the fascia at the...
4.
Imagami T, Sugita S, Nagasaki T, Kimura M, Ito K, Inaguma S
Int J Surg Case Rep
. 2020 May;
71:19-22.
PMID: 32428827
Introduction: The occurrence of sporadic colonic neurofibroma particularly in a patient without neurofibromatosis type 1 has been rarely reported. Therefore, the clinical significance of this disease has not been fully...
5.
Hara M, Shiga K, Yanagita T, Nakai N, Ando N, Takasu K, et al.
Surg Today
. 2019 Feb;
49(7):621-628.
PMID: 30739170
Purpose: We evaluated the perioperative inflammatory mediators in a right hemicolectomy performed with single-incision laparoscopic surgery (SILS) and traditional multi-port laparoscopic surgery (MLS) to compare the postoperative inflammatory response and...
6.
Kimura M, Nagasaki T, Kuwabara Y, Tanaka H, Hato M, Taniwaki S, et al.
Int J Surg Case Rep
. 2017 May;
36:86-89.
PMID: 28550789
Introduction: Patients with esophageal cancer frequently cannot tolerate thoracotomy due to their overall debilitated condition. Moreover, some patients have severe adhesions in the thoracic cavity. Eversion stripping of the esophagus...
7.
Kimura M, Shibata Y, Mizuno K, Tanaka H, Hato M, Taniwaki S, et al.
Case Rep Surg
. 2017 Mar;
2017:5862871.
PMID: 28299227
With advances of combined modality therapy, prognoses in esophageal cancer have been improving. After resection of esophageal cancer, the development of gastric tube cancer is a risk. While such cancer...
8.
Hara M, Nagasaki T, Shiga K, Takahashi H, Takeyama H
Surg Today
. 2016 Aug;
47(4):483-489.
PMID: 27549777
Purpose: We evaluated the relationship of the pretreatment serum IL-6 levels with the outcome and treatment response in patients with advanced or metastatic colorectal cancer (CRC) who underwent bevacizumab-containing chemotherapy....
9.
Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Sato M, et al.
Gastroenterol Res Pract
. 2016 Feb;
2016:9701574.
PMID: 26858756
Aims. To evaluate the prognostic significance of serum interleukin-6 (IL-6) in colorectal cancer (CRC). Patients and Methods. Preoperative serum IL-6 was measured in 233 CRC patients and 13 healthy controls....
10.
Hara M, Nagasaki T, Shiga K, Takeyama H
Anticancer Res
. 2016 Jan;
36(1):169-77.
PMID: 26722041
Background: We evaluated the ability of itraconazole to enhance the effects of bevacizumab in bevacizumab-resistant cancer cells, endothelial cells, and cancer-associated fibroblasts (CAFs). Materials And Methods: Human gastrointestinal cancer cell...